-
1
-
-
0029153165
-
New antiplatelet agents: Platelet GPIIb/IIIa antagonists
-
Coller, B. S.; Anderson, K.; Weisman, H. F. New antiplatelet agents: platelet GPIIb/IIIa antagonists. Thromb. Haemost. 1995, 74, 302-308.
-
(1995)
Thromb. Haemost.
, vol.74
, pp. 302-308
-
-
Coller, B.S.1
Anderson, K.2
Weisman, H.F.3
-
2
-
-
0025224552
-
Platelet membrane glycoproteins: Functions in cellular adhesion and aggregation
-
Kieffer, N.; Phillips, D. R. Platelet Membrane Glycoproteins: Functions in Cellular Adhesion and Aggregation. Annu. Rev. Cell. Biol. 1990, 6, 329-357.
-
(1990)
Annu. Rev. Cell. Biol.
, vol.6
, pp. 329-357
-
-
Kieffer, N.1
Phillips, D.R.2
-
3
-
-
0029062761
-
Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine
-
See: (a) Lefkovits, J.; Plow, E. F.; Topol, E. J. Platelet Glycoprotein IIb/IIIa Receptors in Cardiovascular Medicine. N. Engl. J. Med. 1995, 332, 1553-1559.
-
(1995)
N. Engl. J. Med.
, vol.332
, pp. 1553-1559
-
-
Lefkovits, J.1
Plow, E.F.2
Topol, E.J.3
-
5
-
-
0025814801
-
Arginyl-glycyl-aspartic acid (RGD): A cell adhesion motif
-
D'Souza, S. E.; Ginsberg, M. H.; Plow, E. F. Arginyl-glycyl-aspartic acid (RGD): A Cell Adhesion Motif. Trends Biochem. Sci. 1991, 16, 246-250.
-
(1991)
Trends Biochem. Sci.
, vol.16
, pp. 246-250
-
-
D'Souza, S.E.1
Ginsberg, M.H.2
Plow, E.F.3
-
6
-
-
0026671678
-
-
Nichols, A. J.; Ruffolo, R. R., Jr.; Huffman, W. H.; Poste, G.; Samanen, J. Trends Pharmacol. Sci. 1992, 13, 413.
-
(1992)
Trends Pharmacol. Sci.
, vol.13
, pp. 413
-
-
Nichols, A.J.1
Ruffolo R.R., Jr.2
Huffman, W.H.3
Poste, G.4
Samanen, J.5
-
7
-
-
0025989573
-
Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro
-
Samanen, J.; Ali, F.; Romoff, T.; Calvo, R.; Sorenson, E.; Vasko, J.; Storer, B.; Berry, D.; Bennett, D.; Stroksacker, M.; Powers, D.; Stadel, J.; Nichols, A. Development of a Small RGD Peptide Fibrinogen Receptor Antagonist with Potent Antiaggregatory Activity in Vitro. J. Med. Chem. 1991, 34, 3114-3125.
-
(1991)
J. Med. Chem.
, vol.34
, pp. 3114-3125
-
-
Samanen, J.1
Ali, F.2
Romoff, T.3
Calvo, R.4
Sorenson, E.5
Vasko, J.6
Storer, B.7
Berry, D.8
Bennett, D.9
Stroksacker, M.10
Powers, D.11
Stadel, J.12
Nichols, A.13
-
8
-
-
0007791454
-
Development of novel, highly selective fibrinogen receptor antagonists as potentially useful antithrombotic agents
-
Smith, J. A., River, J. E., Eds.; ESCOM: Leiden, The Netherlands
-
Nutt, R. F.; Brady, S. F.; Colton, C. D.; Sisko, J. T.; Ciccarone, T.; Levey, M. R.; Duggan, M. E.; Imagire, I. S.; Gould, R. J.; Anderson, P. S.; Veber, D. F. Development of Novel, Highly Selective Fibrinogen Receptor Antagonists as Potentially Useful Antithrombotic Agents. In Peptides: Chemistry and Biology. Proceedings of the Twelfth American Peptide Symposium; Smith, J. A., River, J. E., Eds.; ESCOM: Leiden, The Netherlands, 1992; pp 914-916.
-
(1992)
Peptides: Chemistry and Biology. Proceedings of the Twelfth American Peptide Symposium
, pp. 914-916
-
-
Nutt, R.F.1
Brady, S.F.2
Colton, C.D.3
Sisko, J.T.4
Ciccarone, T.5
Levey, M.R.6
Duggan, M.E.7
Imagire, I.S.8
Gould, R.J.9
Anderson, P.S.10
Veber, D.F.11
-
9
-
-
0026623091
-
Cyclic RGD analogues as antiplatelet antithrombotics
-
Barker, P. L.; Bullens, S.; Bunting, S.; Burdick, D. J.; Chan, K. S.; Deisher, T.; Eigenbrot, C.; Gadek, T. R.; Gantzos, R.; Lipari, M. T.; Muir, C. D.; Napier, M. A.; Pitti, R. M.; Padua, A.; Quan, C.; Stanley, M.; Struble, M.; Tom, J. Y. K.; Burnier, J. P. Cyclic RGD Analogues as Antiplatelet Antithrombotics. J. Med. Chem. 1992, 35, 2040-2048.
-
(1992)
J. Med. Chem.
, vol.35
, pp. 2040-2048
-
-
Barker, P.L.1
Bullens, S.2
Bunting, S.3
Burdick, D.J.4
Chan, K.S.5
Deisher, T.6
Eigenbrot, C.7
Gadek, T.R.8
Gantzos, R.9
Lipari, M.T.10
Muir, C.D.11
Napier, M.A.12
Pitti, R.M.13
Padua, A.14
Quan, C.15
Stanley, M.16
Struble, M.17
Tom, J.Y.K.18
Burnier, J.P.19
-
10
-
-
0027393671
-
Design of potent and specific integrin antagonists
-
Scarborough, R. M.; Naughton, M. A.; Teng, W.; Rose, J. W.; Phillips, D. R.; Nannizzi, L.; Arfsten, A.; Campbell, A. M.; Charo, I. F. Design of Potent and Specific Integrin Antagonists. J. Biol. Chem. 1993, 268, 1066-1073.
-
(1993)
J. Biol. Chem.
, vol.268
, pp. 1066-1073
-
-
Scarborough, R.M.1
Naughton, M.A.2
Teng, W.3
Rose, J.W.4
Phillips, D.R.5
Nannizzi, L.6
Arfsten, A.7
Campbell, A.M.8
Charo, I.F.9
-
11
-
-
0028345163
-
Conformationally constrained peptides and semipeptides derived from RGD as potent inhibitors of the platelet fibrinogen receptor and platelet aggregation
-
Ali, F. E.; Bennett, D. B.; Raul, C. R.; Elliott, J. D.; Hwand, S. M.; Ku, T. W.; Lago, M. A.; Nichols, A. J.; Romoff, T. T.; Shah, D. H.; Vasko, J. A.; Wong, A. S.; Yellin, T. O.; Yuan, C. K.; Samanen, J. M. Conformationally Constrained Peptides and Semipeptides Derived from RGD as Potent Inhibitors of the Platelet Fibrinogen Receptor and Platelet Aggregation. J. Med. Chem. 1994, 37, 769-780.
-
(1994)
J. Med. Chem.
, vol.37
, pp. 769-780
-
-
Ali, F.E.1
Bennett, D.B.2
Raul, C.R.3
Elliott, J.D.4
Hwand, S.M.5
Ku, T.W.6
Lago, M.A.7
Nichols, A.J.8
Romoff, T.T.9
Shah, D.H.10
Vasko, J.A.11
Wong, A.S.12
Yellin, T.O.13
Yuan, C.K.14
Samanen, J.M.15
-
12
-
-
0028049293
-
III antagonists
-
III Antagonists. J. Med. Chem. 1994, 37, 1-8.
-
(1994)
J. Med. Chem.
, vol.37
, pp. 1-8
-
-
Cheng, S.1
Craig, W.S.2
Mullen, D.3
Tschopp, J.F.4
Dixon, D.5
Pierschbacher, M.D.6
-
13
-
-
0028353015
-
Template-constrained cyclic peptides: Design of high-affinity ligands for GPIIb/IIIa
-
Jackson, S.; DeGrado, W.; Dwivedi, A.; Parthasarathy, A.; Higley, A.; Krywko, J.; Rockwell, A.; Markwalder, J.; Wells, G.; Wexler, R.; Mousa, S.; Harlow, R. Template-Constrained Cyclic Peptides: Design of High-Affinity Ligands for GPIIb/IIIa. J. Am. Chem. Soc. 1994, 116, 3220-3230.
-
(1994)
J. Am. Chem. Soc.
, vol.116
, pp. 3220-3230
-
-
Jackson, S.1
DeGrado, W.2
Dwivedi, A.3
Parthasarathy, A.4
Higley, A.5
Krywko, J.6
Rockwell, A.7
Markwalder, J.8
Wells, G.9
Wexler, R.10
Mousa, S.11
Harlow, R.12
-
14
-
-
0028711918
-
Pharmacophore refinement of gpIIb/IIIa antagonists based on comparative studies of anti-adhesive cyclic and acyclic rgd peptides
-
Muller, G.; Gurrath, M.; Kessler, H. Pharmacophore refinement of gpIIb/IIIa antagonists based on comparative studies of anti-adhesive cyclic and acyclic RGD peptides. J. Comput. Aided. Mol. Des. 1994, 8, 709-730.
-
(1994)
J. Comput. Aided. Mol. Des.
, vol.8
, pp. 709-730
-
-
Muller, G.1
Gurrath, M.2
Kessler, H.3
-
15
-
-
0027051496
-
Conformations of Arg-Gly-Asp containing heterodetic cyclic peptides: Solution and crystal studies
-
Kopple, K. D.; Baures, P. W.; Bean, J. W.; D'Ambrosio, C. A.; Hughes, J. L.; Peishoff, C. E.; Eggleston, D. S. Conformations of Arg-Gly-Asp Containing Heterodetic Cyclic Peptides: Solution and Crystal Studies. J. Am. Chem. Soc. 1992, 114, 9615-9623.
-
(1992)
J. Am. Chem. Soc.
, vol.114
, pp. 9615-9623
-
-
Kopple, K.D.1
Baures, P.W.2
Bean, J.W.3
D'Ambrosio, C.A.4
Hughes, J.L.5
Peishoff, C.E.6
Eggleston, D.S.7
-
16
-
-
0026483379
-
Investigation of conformational specificity at GPIIb/IIIa: Evaluation of conformationally constrained RGD peptides
-
Peishoff, C. E.; Ali, F. E.; Bean, J. W.; Calvo, R.; D'Ambrosio, C. A.; Eggleston, D. S.; Hwang, S. M.; Kline, T. P.; Koster, P. F.; Nichols, A.; Powers, D.; Romoff, T.; Samanen, J. M.; Stadel, J.; Vasko, J. A.; Kopple, K. D. Investigation of Conformational Specificity at GPIIb/IIIa: Evaluation of Conformationally Constrained RGD Peptides. J. Med. Chem. 1992, 35, 3962-3969.
-
(1992)
J. Med. Chem.
, vol.35
, pp. 3962-3969
-
-
Peishoff, C.E.1
Ali, F.E.2
Bean, J.W.3
Calvo, R.4
D'Ambrosio, C.A.5
Eggleston, D.S.6
Hwang, S.M.7
Kline, T.P.8
Koster, P.F.9
Nichols, A.10
Powers, D.11
Romoff, T.12
Samanen, J.M.13
Stadel, J.14
Vasko, J.A.15
Kopple, K.D.16
-
17
-
-
0028306633
-
Structural studies of family of high affinity ligands for GP IIB-IIIa
-
(a) Bach, A. C., II; Eyermann, C. J.; Gross, J. D.; Bower, M. J.; Harlow, R. L.; Weber, P. C.; DeGrado, W. F. Structural Studies of Family of High Affinity Ligands for GP IIB-IIIa. J. Am. Chem. Soc. 1994, 116, 3207-3219.
-
(1994)
J. Am. Chem. Soc.
, vol.116
, pp. 3207-3219
-
-
Bach A.C. II1
Eyermann, C.J.2
Gross, J.D.3
Bower, M.J.4
Harlow, R.L.5
Weber, P.C.6
DeGrado, W.F.7
-
18
-
-
8044236449
-
Discovery of potent isoxazoline glycoprotein IIb/IIIa receptor antagonists
-
(b) Wityak, J.; Sielecki, T. M.; Pinto, D. J.; Emmet, G.; Sze, J. Y.; Liu, J.; Tobin, E.; Wang, S.; Jiang, B.; Ma, P.; Mousa, S. A.; Wexler, R. R.; Olson, R. Discovery of Potent Isoxazoline Glycoprotein IIb/IIIa Receptor Antagonists. J. Med. Chem. 1997, 40, 50-60.
-
(1997)
J. Med. Chem.
, vol.40
, pp. 50-60
-
-
Wityak, J.1
Sielecki, T.M.2
Pinto, D.J.3
Emmet, G.4
Sze, J.Y.5
Liu, J.6
Tobin, E.7
Wang, S.8
Jiang, B.9
Ma, P.10
Mousa, S.A.11
Wexler, R.R.12
Olson, R.13
-
19
-
-
0027948111
-
Orally active non-peptide fibrinogen receptor (GPIIb/IIIa) antagonists: Identification of 4-[4 - 4(aminoimino-methyl)phenyl]-1-piperazinyl-1-piperidineacetic acid as a long-acting, broad-spectrum antithrombotic agent
-
Eldred, C. P.; Evans, B.; Hindley, S.; Judkins, B. D.; Kelly, H. A.; Kitchin, J.; Lumley, B. D.; Porter, B.; Ross, B. C.; Smith, K. J.; Taylor, N. R.; Wheatcroft, J. R. Orally Active Non-Peptide Fibrinogen Receptor (GPIIb/IIIa) Antagonists: Identification of 4-[4-(-4(Aminoimino-methyl)Phenyl]-1-Piperazinyl-1-Piperidineacetic acid as a Long-Acting, Broad-Spectrum Antithrombotic Agent. J. Med. Chem. 1994, 37, 3882-3885.
-
(1994)
J. Med. Chem.
, vol.37
, pp. 3882-3885
-
-
Eldred, C.P.1
Evans, B.2
Hindley, S.3
Judkins, B.D.4
Kelly, H.A.5
Kitchin, J.6
Lumley, B.D.7
Porter, B.8
Ross, B.C.9
Smith, K.J.10
Taylor, N.R.11
Wheatcroft, J.R.12
-
20
-
-
0028048161
-
From peptide to non-peptide. 1. The elucidation of a bioactive conformation of the arginine-glycine-aspartic acid recognition sequence
-
(a) McDowell, R. S.; Gadek, T. R.; Barker, P. L.; Burdick, D. J.; Chan, K. S.; Quan, C. L.; Skelton, N.; Struble, M.; Thorsett, E. D.; Tischler, M.; Tom, J. Y. K.; Webb, T. R.; Burnler, J. P. From Peptide to Non-Peptide. 1. The Elucidation of a Bioactive Conformation of the Arginine-Glycine-Aspartic Acid Recognition Sequence. J. Am. Chem. Soc. 1994, 116, 5069-5077.
-
(1994)
J. Am. Chem. Soc.
, vol.116
, pp. 5069-5077
-
-
McDowell, R.S.1
Gadek, T.R.2
Barker, P.L.3
Burdick, D.J.4
Chan, K.S.5
Quan, C.L.6
Skelton, N.7
Struble, M.8
Thorsett, E.D.9
Tischler, M.10
Tom, J.Y.K.11
Webb, T.R.12
Burnler, J.P.13
-
21
-
-
0027964423
-
From peptide to non-peptide. 2. The de novo design of potent, non-peptidal inhibitors of platelet aggregation based on a benzodiazepinedione scaffold
-
(b) McDowell, R. S.; Blackburn, B. K.; Gadek, T. R.; McGee, L. R.; Rawson, T.; Reynolds, M. E.; Robarge, K. D.; Somers, T. C.; Thorsett, E. D.; Tischler, M.; Webb, R. R.; Venuti, M. C. From Peptide to Non-Peptide. 2. The de Novo Design of Potent, Non-Peptidal Inhibitors of Platelet Aggregation Based on a Benzodiazepinedione Scaffold. J. Am. Chem. Soc. 1994, 116, 5077-5083.
-
(1994)
J. Am. Chem. Soc.
, vol.116
, pp. 5077-5083
-
-
McDowell, R.S.1
Blackburn, B.K.2
Gadek, T.R.3
McGee, L.R.4
Rawson, T.5
Reynolds, M.E.6
Robarge, K.D.7
Somers, T.C.8
Thorsett, E.D.9
Tischler, M.10
Webb, R.R.11
Venuti, M.C.12
-
22
-
-
14444269454
-
Non-peptide RGD surrogates which mimic a Gly-Asp β-turn: Potent antagonists of platelet glycoprotein IIb-IIIa
-
Fisher, M. J.; Gunn, B.; Harms, C. S.; Kline, A. D.; Mullaney, J. T.; Nunes, A.; Scarborough, R. M.; Arfsen, A. E.; Skelton, M. A.; Um, S. L.; Utterback, B. G.; Jacubowski, J. A. Non-Peptide RGD Surrogates Which Mimic a Gly-Asp β-turn: Potent Antagonists of Platelet Glycoprotein IIb-IIIa. J. Med. Chem. 1997, 40, 2085-2101.
-
(1997)
J. Med. Chem.
, vol.40
, pp. 2085-2101
-
-
Fisher, M.J.1
Gunn, B.2
Harms, C.S.3
Kline, A.D.4
Mullaney, J.T.5
Nunes, A.6
Scarborough, R.M.7
Arfsen, A.E.8
Skelton, M.A.9
Um, S.L.10
Utterback, B.G.11
Jacubowski, J.A.12
-
23
-
-
84982506235
-
The first design and synthesis of a steroidal peptidomimetic. The potential value of peptidomimetics in elucidating the bioactive conformation of peptide ligands
-
Hirschmann, R.; Sprengeler, P. A.; Kawasaki, T.; Leahy, J. W., Shakespeare, W. C.; Smith, A. B., III. The First Design and Synthesis of a Steroidal Peptidomimetic. The Potential Value of Peptidomimetics in Elucidating the Bioactive Conformation of Peptide Ligands. J. Am. Chem. Soc. 1992, 114, 9699-9701.
-
(1992)
J. Am. Chem. Soc.
, vol.114
, pp. 9699-9701
-
-
Hirschmann, R.1
Sprengeler, P.A.2
Kawasaki, T.3
Leahy, J.W.4
Shakespeare, W.C.5
Smith A.B. III6
-
24
-
-
0029055340
-
Antithrombotic agents: From RGD to peptide mimetics
-
For recent reviews of the progress in the development of nonpeptide IIb/IIIa antagonists, see ref 3b and: Ojima, I.; Chakravarty, S.; Dong, Q. Antithrombotic agents: from RGD to peptide mimetics. Bioorg. Med. Chem. 1995, 3, 337-360.
-
(1995)
Bioorg. Med. Chem.
, vol.3
, pp. 337-360
-
-
Ojima, I.1
Chakravarty, S.2
Dong, Q.3
-
25
-
-
0026615094
-
Design and synthesis of a C7 mimetic for the predicted γ-turn conformation found in several constrained RGD antagonists
-
Callahan, J. F.; Bean, J. W.; Burgess, J. L.; Eggleston, D. E.; Hwang, S. M.; Kopple, K. D.; Koster, P. F.; Nichols, A.; Peishoff, C. E.; Samanen, J. M.; Vasko, J. A.; Wong, A.; Huffman, W. F. Design and Synthesis of a C7 Mimetic for the Predicted γ-turn Conformation Found in Several Constrained RGD Antagonists. J. Med. Chem., 1992, 35, 3970-3972.
-
(1992)
J. Med. Chem.
, vol.35
, pp. 3970-3972
-
-
Callahan, J.F.1
Bean, J.W.2
Burgess, J.L.3
Eggleston, D.E.4
Hwang, S.M.5
Kopple, K.D.6
Koster, P.F.7
Nichols, A.8
Peishoff, C.E.9
Samanen, J.M.10
Vasko, J.A.11
Wong, A.12
Huffman, W.F.13
-
26
-
-
0027495004
-
Direct design of a potent non-peptide fibrinogen receptor antagonist based on the structure and conformation of a highly constrained cyclic RGD peptide
-
Ku, T. W.; Ali, F. E.; Barton, L. S.; Bean, J. W.; Bondinell, W. E.; Burgess, J. L.; Callahan, J. F.; Calvo, R. R.; Chen, L.; Eggleston, D. S.; Gleason, J. G.; Huffman, W. F.; Hwang, S.-M.; Jakas, D. R.; Karash, C. B.; Keenan, R. M.; Kopple, K. D.; Miller, W. H.; Newlander, K. A.; Nichols, A.; Parker, M. F.; Peishoff, C. E.; Samanen, J. M.; Uzinskas, I.; Venslavsky, J. W. Direct Design of a Potent Non-Peptide Fibrinogen Receptor Antagonist Based on the Structure and Conformation of a Highly Constrained Cyclic RGD Peptide. J. Am. Chem. Soc. 1993, 115, 8861-8862.
-
(1993)
J. Am. Chem. Soc.
, vol.115
, pp. 8861-8862
-
-
Ku, T.W.1
Ali, F.E.2
Barton, L.S.3
Bean, J.W.4
Bondinell, W.E.5
Burgess, J.L.6
Callahan, J.F.7
Calvo, R.R.8
Chen, L.9
Eggleston, D.S.10
Gleason, J.G.11
Huffman, W.F.12
Hwang, S.-M.13
Jakas, D.R.14
Karash, C.B.15
Keenan, R.M.16
Kopple, K.D.17
Miller, W.H.18
Newlander, K.A.19
Nichols, A.20
Parker, M.F.21
Peishoff, C.E.22
Samanen, J.M.23
Uzinskas, I.24
Venslavsky, J.W.25
more..
-
27
-
-
0028512485
-
Design of a potent and orally active nonpeptide platelet fibrinogen receptor (GPIIB/IIIA) antagonist
-
(a) Bondinell, W. E.; Keenan, R. M.; Miller, W. H.; Ali, F. E.; Allen, A. C.; DeBrosse, C. W.; Eggleston, D. S.; Erhard, K. F.; Haltiwanger, R. C.; Lee, C. P.; Nichols, A. J.; Ross, S. T.; Samanen, J. M.; Valocik, R. E.; Vasko-Moser, J. A.; Venslavsky, J. W.; Wong, A. S.; Yuan, C. K. Design of a Potent and Orally Active Nonpeptide Platelet Fibrinogen Receptor (GPIIB/IIIA) Antagonist. Bioorg. Med. Chem. 1994, 2, 897-908.
-
(1994)
Bioorg. Med. Chem.
, vol.2
, pp. 897-908
-
-
Bondinell, W.E.1
Keenan, R.M.2
Miller, W.H.3
Ali, F.E.4
Allen, A.C.5
DeBrosse, C.W.6
Eggleston, D.S.7
Erhard, K.F.8
Haltiwanger, R.C.9
Lee, C.P.10
Nichols, A.J.11
Ross, S.T.12
Samanen, J.M.13
Valocik, R.E.14
Vasko-Moser, J.A.15
Venslavsky, J.W.16
Wong, A.S.17
Yuan, C.K.18
-
28
-
-
0344091182
-
-
Manuscript in preparation
-
(b) Bondinell, W. E.; et al. Manuscript in preparation.
-
-
-
Bondinell, W.E.1
-
29
-
-
0029775672
-
Potent, selective, orally active 3-oxo-1,4-benzodiazepine GPIIb/IIIa integrin antagonists
-
Samanen, J. M.; Ali, F. E.; Barton, L. S.; Bondinell, W. E.; Burgess, J. L.; Callahan, J. F.; Calvo, R. R.; Chen, W.; Chen, L.; Erhard, K.; Feuerstein, G.; Heys, R.; Hwang, S.-M.; Jakas, D. R.; Keenan, R. M.; Koster, P. F.; Ku, T. W.; Kwon, C.; Lee, C.-P.; Miller, W. H.; Newlander, K. A.; Nichols, A.; Parker, M.; Peishoff, C. E.; Rhodes, G.; Ross, S.; Shu, A.; Simpson, R.; Takata, D.; Vasko-Moser, J. A.; Valocik, R. E.; Yellin, T. O.; Uzinskas, I.; Venslavsky, J. W.; Wong, A.; Yuan, C.-K.; Huffman, W. F. Potent, Selective, Orally Active 3-Oxo-1,4-benzodiazepine GPIIb/IIIa Integrin Antagonists. J. Med. Chem. 1996, 39, 4867-4870.
-
(1996)
J. Med. Chem.
, vol.39
, pp. 4867-4870
-
-
Samanen, J.M.1
Ali, F.E.2
Barton, L.S.3
Bondinell, W.E.4
Burgess, J.L.5
Callahan, J.F.6
Calvo, R.R.7
Chen, W.8
Chen, L.9
Erhard, K.10
Feuerstein, G.11
Heys, R.12
Hwang, S.-M.13
Jakas, D.R.14
Keenan, R.M.15
Koster, P.F.16
Ku, T.W.17
Kwon, C.18
Lee, C.-P.19
Miller, W.H.20
Newlander, K.A.21
Nichols, A.22
Parker, M.23
Peishoff, C.E.24
Rhodes, G.25
Ross, S.26
Shu, A.27
Simpson, R.28
Takata, D.29
Vasko-Moser, J.A.30
Valocik, R.E.31
Yellin, T.O.32
Uzinskas, I.33
Venslavsky, J.W.34
Wong, A.35
Yuan, C.-K.36
Huffman, W.F.37
more..
-
30
-
-
16044369444
-
Structure-activity relationships in 3-oxo-1,4-benzodiazepine-2-acetic acid GPIIb/IiIa antagonists. The 2-benzazepine series
-
Miller, W. H.; Bondinell, W. E.; Callahan, J. F.; Eggleston, D. S.; Huffman, W. F.; Hwang, S. M.; Jakas, D. R.; Keenan, R. M.; Koster, P. F.; Ku, T. W.; Kwon, C. K.; Nichols, A. J.; Samanen, J. M.; Takata, D. T.; Uzinskas, I. N.; Valocik, R. E.; Vasko-Moser, J. A.; Wong, A. S. Structure-Activity Relationships in 3-Oxo-1,4-benzodiazepine-2-acetic Acid GPIIb/IIIa Antagonists. The 2-Benzazepine Series. Bioorg. Med. Chem. Lett. 1996, 6, 2481-2486.
-
(1996)
Bioorg. Med. Chem. Lett.
, vol.6
, pp. 2481-2486
-
-
Miller, W.H.1
Bondinell, W.E.2
Callahan, J.F.3
Eggleston, D.S.4
Huffman, W.F.5
Hwang, S.M.6
Jakas, D.R.7
Keenan, R.M.8
Koster, P.F.9
Ku, T.W.10
Kwon, C.K.11
Nichols, A.J.12
Samanen, J.M.13
Takata, D.T.14
Uzinskas, I.N.15
Valocik, R.E.16
Vasko-Moser, J.A.17
Wong, A.S.18
-
31
-
-
0344953203
-
-
WO 9414776, July 7
-
Bondinell, W. E.; Callahan, J. F.; Huffman, W. F.; Keenan, R. M.; Ku, T. W.; Newlander, K. A.; Samanen, J. M.; Uzinskas, I. N. WO 9414776, July 7, 1994.
-
(1994)
-
-
Bondinell, W.E.1
Callahan, J.F.2
Huffman, W.F.3
Keenan, R.M.4
Ku, T.W.5
Newlander, K.A.6
Samanen, J.M.7
Uzinskas, I.N.8
-
32
-
-
0028877709
-
Synthesis of a 2-benzazepine analogue of a potent, nonpeptide GPIIb/IIIa antagonist
-
Miller, W. H.; Newlander, K. A.; Eggleston, D. S.; Haltiwanger, R. C.; Synthesis of a 2-Benzazepine Analogue of a Potent, Nonpeptide GPIIb/IIIa Antagonist. Tetrahedron Lett. 1995, 36, 373-376.
-
(1995)
Tetrahedron Lett.
, vol.36
, pp. 373-376
-
-
Miller, W.H.1
Newlander, K.A.2
Eggleston, D.S.3
Haltiwanger, R.C.4
-
33
-
-
0344953202
-
-
For a full description of the in vitro assays, see ref 24a
-
For a full description of the in vitro assays, see ref 24a.
-
-
-
-
34
-
-
0031031113
-
The use of rabbit intestinal permeability as an in vitro assay in the search for orally active GPIIb/IIIa antagonists
-
The intestinal permeability of these compounds was the subject of a recent review; See: Samanen, J. M.; Lee, C.-P.; Smith, P. L.; Bondinell, W.; Calvo, R. R.; Jakas, D. R.; Newlander, K.; Parker, M.; Uzinskas, I.; Yellin, T. O.; Nichols, A. J. The Use of Rabbit Intestinal Permeability as an in vitro Assay in the Search for Orally Active GPIIb/IIIa Antagonists. Adv. Drug Deliv. Rev. 1996, 23, 133-142.
-
(1996)
Adv. Drug Deliv. Rev.
, vol.23
, pp. 133-142
-
-
Samanen, J.M.1
Lee, C.-P.2
Smith, P.L.3
Bondinell, W.4
Calvo, R.R.5
Jakas, D.R.6
Newlander, K.7
Parker, M.8
Uzinskas, I.9
Yellin, T.O.10
Nichols, A.J.11
-
35
-
-
0027096411
-
Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitors
-
For prototypical acyclic nonpeptide fibrinogen receptor antagonists, see: (a) Hartman, G. D.; Egbertson, M. S.; Halczenko, W.; Laswell, W. L.; Duggan, M. E.; Smith, R. L.; Naylor, A. M.; Manno, P. D.; Lynch, R. J.; Zhang, G.; et al. Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitors. J. Med. Chem. 1992, 35, 4640-4642.
-
(1992)
J. Med. Chem.
, vol.35
, pp. 4640-4642
-
-
Hartman, G.D.1
Egbertson, M.S.2
Halczenko, W.3
Laswell, W.L.4
Duggan, M.E.5
Smith, R.L.6
Naylor, A.M.7
Manno, P.D.8
Lynch, R.J.9
Zhang, G.10
-
36
-
-
0029067684
-
Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp sequence of fibrinogen. (aminobenzamidino)succinyl (ABAs) series of orally active fibrinogen receptor antagonists
-
(b) Zablocki, J. A.; Rico, J. G.; Garland, R. B.; Rogers, T. E.; Williams, K.; Schretzman, L. A.; Rao, S. A.; Bovy, P. R.; Tjoeng, F. S.; Lindmark, R. J.; Toth, M. V.; Zupec, M. E.; McMackins, D. E.; Adams, S. P.; Miyano, M.; Markos, C. S.; Milton, M. N.; Paulson, S.; Herin, M.; et al. Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp sequence of fibrinogen. (Aminobenzamidino)succinyl (ABAS) series of orally active fibrinogen receptor antagonists. J. Med. Chem. 1995, 38, 2378-2394.
-
(1995)
J. Med. Chem.
, vol.38
, pp. 2378-2394
-
-
Zablocki, J.A.1
Rico, J.G.2
Garland, R.B.3
Rogers, T.E.4
Williams, K.5
Schretzman, L.A.6
Rao, S.A.7
Bovy, P.R.8
Tjoeng, F.S.9
Lindmark, R.J.10
Toth, M.V.11
Zupec, M.E.12
McMackins, D.E.13
Adams, S.P.14
Miyano, M.15
Markos, C.S.16
Milton, M.N.17
Paulson, S.18
Herin, M.19
-
37
-
-
0345384653
-
-
Monte Carlo simulations were done using MacroModel version 6.0 (Department of Chemistry, Columbia University, New York)
-
Monte Carlo simulations were done using MacroModel version 6.0 (Department of Chemistry, Columbia University, New York).
-
-
-
-
38
-
-
0344091178
-
-
note
-
Minimizations within BatchMin V6.0 (Department of Chemistry, Columbia University, New York) were performed using AMBER*. All force-field equations are identical with those of authentic AMBER from P. Kollman.
-
-
-
-
39
-
-
0344522303
-
-
note
-
The biological activity for the benzodiazepine series has been shown to reside in the (S)-configuration at the acetic acid stereocenter, as in L-aspartic acid; see refs 24a and 25.
-
-
-
-
40
-
-
0031040820
-
From peptide to non-peptide. 3. Atropisomeric GPIIbIIIa antagonists containing the 3,4-dihydro-1h-1,4-benzodiazepine-2,5-dione nucleus
-
Blackburn, B. K.; Lee, A.; Baier, M.; Kohl, B.; Olivero, A. G.; Matamoros, R.; Robarge, K. D.; McDowell, R. S. From peptide to non-peptide. 3. Atropisomeric GPIIbIIIa antagonists containing the 3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione nucleus. J. Med. Chem. 1997, 40, 717-729.
-
(1997)
J. Med. Chem.
, vol.40
, pp. 717-729
-
-
Blackburn, B.K.1
Lee, A.2
Baier, M.3
Kohl, B.4
Olivero, A.G.5
Matamoros, R.6
Robarge, K.D.7
McDowell, R.S.8
|